EDRS
TOVX icon

Edmond de Rothschild (Suisse)’s Theriva Biologics TOVX Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$499K Buy
33
+1
+3% +$15K 0.15% 132
2016
Q2 		$504K Buy
32
+6
+23% +$113K 0.17% 117
2016
Q1 		$543K Buy
26
+9
+53% +$135K 0.22% 97
2015
Q4 		$344K Hold
17
– – 0.13% 108
2015
Q3 		$340K Buy
+17
New +$418K 0.11% 117

Other funds holding TOVX

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s TOVX Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) increased its Theriva Biologics (TOVX) stake by 3.1% in Q3 2016, buying an estimated $15K and bringing the position to 33 shares worth $499K. The position accounts for 0.15% of the portfolio, ranked #132.

Edmond de Rothschild (Suisse) first reported a position in TOVX in Q3 2015 and has held it in 5 quarters since. The position peaked at $543K in Q1 2016. 60 funds tracked by Wall St. Rank hold TOVX as of Q3 2016.

  • Edmond de Rothschild (Suisse) held 33 shares of Theriva Biologics worth $499K as of Q3 2016.
  • Edmond de Rothschild (Suisse) bought 1 Theriva Biologics share in Q3 2016, an estimated $15K.
  • Theriva Biologics made up 0.15% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #132 holding.
  • Edmond de Rothschild (Suisse) first reported a position in Theriva Biologics in Q3 2015 and has held it in 5 quarters since.
  • Edmond de Rothschild (Suisse)'s Theriva Biologics position peaked at $543K in Q1 2016.
  • 60 funds tracked by Wall St. Rank held Theriva Biologics as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.